TIS 0.00% 0.0¢ tissue therapies limited

mercer should go..., page-3

  1. gkm
    331 Posts.
    Pretty much posts like this one from BigRedRoo proves that not many end up rich investing in stocks. They are so concerned about day to day price movements that the stress by itself makes them lose sight of the bigger picture and eventually sell cheap.

    Not that I am saying BigRedRoo or resouced will sell - but who knows - if there is another delay and we hit August - price falls and they could get convinced.

    A savvy investor on the other hand will try and eliminate as much day to day (or month to month) noise as possible and load up whenever retail investors get frustrated.

    Its simply a matter of keeping your eye on the ball.

    I am not sure how long you have been invested BigRedRoo - but i would defend the management of TIS any time of the day. You know why - because my TIS investment is up 80% since I first bought and the product is not commercial as yet! Figure that!

    Again a perspective issue more than anything.

    Pretty easy to take a gun and shoot the CEO but pretty difficult to accept the fact that what he gets in terms of total compensation from the company is much much much less than what 80% of Practicing Surgeons make in our country. And he was a practicing surgeon. His motivation too are the shares and it is equally in his interest to see them grow.

    Next time - try something more substantial and "investor intelligent" than just delay delay delay. I have been involved with 9 of the largest Pharma's budgets through various channels. Each of them have a risk factor and an estimated cost due to regulatory, logistics, & governance delays. It is a FACT of the Biotech & Pharmaceutical industry and BEYOND the control of ANY CEO.

    Dont mean to have a go at you - but mate - get over it and do some background study on this industry before posting something. That will help your investments.

    My opinion only - dyor.

 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.